Phase I Trial of Neoadjuvant Preoperative Chemotherapy With S-1 and Irinotecan Plus Radiation in Patients With Locally Advanced Rectal Cancer
Authors:
- Yukihito KokubaYKYukihito Kokuba
- Wasaburo KoizumiWKWasaburo Koizumi
- Kazushige HayakawaKHKazushige Hayakawa
- Isao OkayasuIOIsao Okayasu
- Masahiko WatanabeMWMasahiko Watanabe
- 1 December 2007
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 69 (5) , 1442-1447
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cancer Incidence and Incidence Rates in Japan in 2000: Estimates Based on Data from 11 Population-Based Cancer RegistriesJapanese Journal of Clinical Oncology, 2006
- Colorectal cancerThe Lancet, 2005
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerNew England Journal of Medicine, 2004
- Randomized phase II trial of preoperative combined modality chemoradiation for distal rectal cancerJournal of Clinical Oncology, 2004
- Phase II study of oral S‐1 for treatment of metastatic colorectal carcinomaCancer, 2004
- Plasma concentrations of 5-fluorouracil and F-β-alanine following oral administration of S-1, a dihydropyrimidine dehydrogenase inhibitory fluoropyrimidine, as compared with protracted venous infusion of 5-fluorouracilBritish Journal of Cancer, 2003
- Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2000
- Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinomaBritish Journal of Cancer, 2000
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialThe Lancet, 2000